用于冠状动脉干预的药物涂层气球:集中审查
Akash H Patel1, Mark W Abdelnour1, Antonio H Frangieh1
1University of California Irvine, Irvine, California, US.
Methodist DeBakey cardiovascular journal
|August 18, 2025
概括
药物涂层气球 (DCBs) 为冠状动脉疾病 (CAD) 的支架提供了一个有希望的替代方案. 这些设备提供药物来减少缩,在各种类型的病变中显示出有效性,并可能降低与金属植入物相关的风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 生物材料科学 生物材料科学
背景情况:
- 基于导管的干预已经改变了冠状动脉疾病 (CAD) 的治疗方法.
- 药物涂层气球 (DCB) 代表了一项进步,将抗增殖药物输送到血管壁.
- DCBs为永久金属植入物提供了替代品,可能降低血栓形成风险.
研究的目的:
- 审查DCB在CAD管理中的演变和临床应用.
- 专注于DCB在治疗静脉静脉复缩 (ISR),新生病变和复杂的冠状动脉解剖学的作用.
- 评估DCB作为传统支架治疗的替代方案.
主要方法:
- 对DCB技术和CAD的临床结果研究的文献综述.
- 对各种病变子集的DCB疗效的分析,包括ISR,小血管,分叉和长扩散病变.
- 在相关患者群体中比较DCB性能与药物释放支架.
主要成果:
- 在治疗ISR方面,DCB已经证明了其有效性.
- 最近的研究表明,DCB在复杂的病变和小血管中的应用扩大了.
- 在特定的患者群体和病变类型中,DCB已经显示出与药物释放支架的非劣势性.
- 挑战包括冠状动脉剖析的可能性和需要最佳的病变准备.
结论:
- DCBs显示出强大的潜力,可以减少复并改善CAD的长期结果.
- 与传统支架相比,它们提供了一种多功能,有效和潜在的更安全的方法.
- 需要进一步的研究来优化DCB在非标签说明中的使用.
更多相关视频
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
6.9K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.6K
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
676
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
676
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
01:28Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26